Clinical Trials Browser

Phase 1 × OTHER × surufatinib × Clear all

NCT03879057 2019-10-01

Trial of Surufatinib Combined With JS001 in the Treatment of Advanced Solid Tumors

Phase 1 Unknown

Other solid neoplasm

Solid Tumor